IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eiger Biopharmaceuticals Inc (72C)

Q1 2025 vs Q2 2025

Comparing institutional holders between quarters

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Propel Bio Management, LLC
UNCHANGED
Shares146,381 from 146,381
Change0 (0%)
Value$423.0K ($0)
Filed 2025-08-13
Status
Propel Bio Management, LLC
UNCHANGED146,381146,38100%$423.0K$423.0K$02025-08-13
Showing 1 of 1 institutions